No description available.

Rechargeable lithium ion and lithium (Li) metal batteries with high energy density and stability are in high demand for the development of electric vehicles and smart grids. Intensive efforts have been devoted to developing high capacity battery electrodes. However, the known high capacity electrode materials experience fast capacity fading and have limited cycle life due to electromechanical degradations, such as fracture of Si-based electrodes and dendrite growth in Li metal electrodes. A fundamental understanding of electromechanical degradation mechanisms of high capacity electrodes will provide insights into strategies for improving their electrochemical performance. Thus, this dissertation focuses on mechanical properties, microstructure changes, and degradation mechanisms of Si composite electrodes and Li metal electrodes. Based on these findings, possible coping strategies are proposed to improve the cycling stability of both electrodes. The poor cycling life of Si-based electrodes is caused by the repeated lithiation/delithiation-induced huge volumetric change in Si particles, which leads to the fracture of particles, excessive formation of solid electrolyte interphase on the newly exposed surface, as well as the loss of electronic conductivity between Si particles and the conductive matrix. The expansion/contraction of Si particles during cycling also causes the changes in the mechanical properties, microstructure, and porosity of Si composite electrodes. Understanding the relationship between mechanical property evolution, microstructure degradation, and capacity fading is essential for the design of Si composite electrodes. Using an environmental nanoindentation system, in situ microscope cell, and electrochemical impedance spectroscopy, I investigated the mechanical properties, cracking behavior, and lithiation/delithiation kinetics of Si composite electrodes made with different polymeric binders, including polyvinylidene fluoride, Nafion, sodium-carboxymethyl cellulose, and sodium-alginate, in their realistic working environment. The mechanical property evolution is determined by the state-of-charge, porosity, irreversible volume change, and mechanical behavior of binders. Periodical crack opening and closing happens in Si composite electrodes prepared with binders that have strong adhesion with Si. Mechanical degradations, e.g., irreversible volume change, cracking, and debonding between binders and Si particles, are correlated with the evolution of lithiation/delithiation kinetics and the capacity fading of Si composite electrodes. Based on these findings, a partial charging approach is proposed and confirmed experimentally to improve the cycling stability of Si composite electrodes. Li metal electrodes suffer from the low Coulombic efficiency, high electrochemical reactivity with the electrolytes, and the safety hazards caused by the uncontrollable dendrite growth during cycling. Mechanical suppression by using solid electrolytes and artificial SEI is a promising strategy to inhibit the formation of Li dendrites. Mechanical properties of bulk and mossy Li are required for designing mechanical inhibitors and improving the stability of the Li | inhibitor interface. Using an environmental nanoindentation system, I studied the mechanical behavior, especially the time-dependent behavior, of bulk Li and porous mossy Li at ambient temperature. By combining finite element (FE) modeling with experiments, a constitutive law was determined for the viscoplastic deformation of Li metal. FE modeling also demonstrates that the elasticity has a negligible influence on the indentation deformation of bulk Li. Flat punch indentation measurements showed that mossy Li has significantly higher deformation and creep resistance than bulk Li despite of its porous microstructure. The mechanical parameters of bulk and mossy Li may be helpful to develop of dendrite-free Li metal electrodes.

La maladie cœliaque ou sprue cœliaque est une intolérance au gluten. Il s’agit d’une maladie inflammatoire de l’intestin liée à l’ingestion de gluten chez des personnes génétiquement susceptibles. Ce désordre présente une forte prévalence puisqu’il touche 1 % de la population mondiale. En l’état actuel des choses, il n’existe aucun outil pharmacologique pour traiter ou pallier à cette maladie. Cependant, grâce aux avancées dans la compréhension de sa pathogenèse, de nouvelles cibles thérapeutiques ont été identifiées. À l’heure actuelle, le seul traitement efficace consiste à suspendre la consommation de l’agent pathogène, à savoir le gluten. Le gluten est un ensemble de protéines de stockage des céréales contenu dans le blé, l’orge et le seigle. Le gluten du blé se subdivise en gluténines et gliadines. Ce sont ces dernières qui semblent les plus impliquées dans la maladie cœliaque. Les gliadines et ses protéines apparentées (i.e. sécalines et hordéines, respectivement dans le seigle et l’orge) sont riches en prolines et en glutamines, les rendant résistantes à la dégradation par les enzymes digestives et celles de la bordure en brosse. Les peptides résultant de cette digestion incomplète peuvent induire des réponses immunitaires acquises et innées. L’objectif principal de cette thèse était de tester un nouveau traitement d’appoint de la maladie cœliaque utile lors de voyages ou d’évènements ponctuels. Dans les années 80, une observation italienne montra l’inhibition de certains effets induits par des gliadines digérées sur des cultures cellulaires grâce à la co-incubation en présence de mannane: un polyoside naturel composé de mannoses. Malheureusement, ce traitement n’était pas applicable in vivo à cause de la dégradation par les enzymes du tractus gastro-intestinales du polymère, de par sa nature osidique. Les polymères de synthèse, grâce à la diversité et au contrôle de leurs propriétés physico-chimiques, se révèlent être une alternative attrayante à ce polymère naturel. L’objectif de cette recherche était d’obtenir un polymère liant la gliadine, capable d’interférer dans la genèse de la maladie au niveau du tube digestif, afin d’abolir les effets délétères induits par la protéine. Tout d’abord, des copolymères de type poly (hydroxyéthylméthacrylate)-co-(styrène sulfonate) (P(HEMA-co-SS)) ont été synthétisés par polymérisation radicalaire contrôlée par transfert d’atome (ATRP). Une petite bibliothèque de polymères a été préparée en faisant varier la masse molaire, ainsi que les proportions de chacun des monomères. Ces polymères ont ensuite été testés quant à leur capacité de complexer la gliadine aux pH stomacal et intestinal et les meilleurs candidats ont été retenus pour des essais cellulaires. Les travaux ont permis de montrer que le copolymère P(HEMA-co-SS) (45:55 mol%, 40 kDa) permettait une séquestration sélective de la gliadine et qu’il abolissait les effets induits par la gliadine sur différents types cellulaires. De plus, ce composé interférait avec la digestion de la gliadine, suggérant une diminution de peptides immunogènes impliqués dans la maladie. Ce candidat a été testé in vivo, sur un modèle murin sensible au gluten, quant à son efficacité vis-à-vis de la gliadine pure et d’un mélange contenant du gluten avec d’autres composants alimentaires. Le P(HEMA-co-SS) a permis de diminuer les effets sur les paramètres de perméabilité et d’inflammation, ainsi que de moduler la réponse immunitaire engendrée par l’administration de gliadine et celle du gluten. Des études de toxicité et de biodistribution en administration aigüe et chronique ont été réalisées afin de démontrer que ce dernier était bien toléré et peu absorbé suite à son administration par la voie orale. Enfin des études sur des échantillons de tissus de patients souffrants de maladie cœliaque ont montré un bénéfice therapeutique du polymère. L’ensemble des travaux présentés dans cette thèse a permis de mettre en évidence le potentiel thérapeutique du P(HEMA-co-SS) pour prévenir les désordres reliés à l’ingestion de gluten, indiquant que ce type de polymère pourrait être exploité dans un avenir proche. / Celiac Disease or celiac sprue is identified as a gluten intolerance. It is an inflammatory disorder of the intestine triggered by the ingestion of gluten in genetically susceptible individuals. This condition is highly prevalent because it affects up to 1% of the worldwide population. Nowadays, there is no pharmacological treatment available to treat or off set to the disease. Due to the huge progress in the understanding of the pathogenesis, new therapeutic targets have been discovered. At the present time, the only effective treatment remains the strict lifelong abandonment of the pathogen agent, gluten. Gluten encompasses the storage proteins in wheat, rye and barley. The wheat gluten is divided into glutenins and gliadins. The latter seem to be the most important trigger in the celiac disease. Gliadins and the related proteins (i.e. secalins and hordeins, respectively in rye and barley) are rich in prolin and glutamin residues, conferring them to be resistant by enzymatic digestion. The resulting peptides of the incomplete process may set off the inflammatory reaction. The main objective of this thesis was to test a new supportive therapy in treating celiac disease, useful in punctual occasion (i.e. during travel or social event when the gluten-free property cannot be ascertained). In the 1980’s, inhibition of some gliadin-induced effects on cell cultures were observed owing to mannan co-incubation. However, this compound, due to his osidic nature, may be cleaved by digestive enzymes in vivo. Synthetic polymers prove to be an attracting alternative owing to the tunability of their physical and chemical properties. The goal of this study was to obtain a polymeric gliadin-binder, interferring with the pathogenesis of the celiac disease in the gastro-intestinal tract, to abrogate the gliadin induced effects. Atom transfer radical polymerization was used to synthesize copolymers of the type poly (hydroxyethylméthacrylate)-co-(styren sulfonate) (P(HEMA-co-SS)). A small library of polymers varying in their molecular weight and in their constituting monomers ratio was prepared. The ability of these polymers to sequester gliadin was assessed at stomacal and intestinal pH. The best candidates were further evaluated in cell cultures. Our results revealed that a selective binding was obtained with the P(HEMA-co-SS) (45:55 mol%, 40 kDa). This compound abolished gliadin-induced effects on various cell lines. In addition, gliadin digestion was hindered, suggesting a decrease in the formation of immunogenic peptides known to trigger the diseases. In vivo experiments were additionally carried out on a murine model of gluten-sensitivity with this polymeric candidate. Its efficacy towards pure gliadin and gluten containing food was tested. P(HEMA-co-SS decreased gliadin–induced effect on permeability and inflammatory parameters and modulated the immune response due to gliadin/gluten gavage. Toxicity and biodistribution studies following acute and chronic administration were performed on murine to demonstrate that the polymer was well tolerated and not absorbed after oral administration. Finally, biopsies of patients suffering from CD disease exhibited therapeutic benefit of the polymer. Altogether, the results presented in this thesis evidenced the potential of P(HEMA-co-SS) to prevent the gluten-induced disorder, indicating that this type of polymer may be useful in a near future.

La maladie cœliaque ou sprue cœliaque est une intolérance au gluten. Il s’agit d’une maladie inflammatoire de l’intestin liée à l’ingestion de gluten chez des personnes génétiquement susceptibles. Ce désordre présente une forte prévalence puisqu’il touche 1 % de la population mondiale. En l’état actuel des choses, il n’existe aucun outil pharmacologique pour traiter ou pallier à cette maladie. Cependant, grâce aux avancées dans la compréhension de sa pathogenèse, de nouvelles cibles thérapeutiques ont été identifiées. À l’heure actuelle, le seul traitement efficace consiste à suspendre la consommation de l’agent pathogène, à savoir le gluten. Le gluten est un ensemble de protéines de stockage des céréales contenu dans le blé, l’orge et le seigle. Le gluten du blé se subdivise en gluténines et gliadines. Ce sont ces dernières qui semblent les plus impliquées dans la maladie cœliaque. Les gliadines et ses protéines apparentées (i.e. sécalines et hordéines, respectivement dans le seigle et l’orge) sont riches en prolines et en glutamines, les rendant résistantes à la dégradation par les enzymes digestives et celles de la bordure en brosse. Les peptides résultant de cette digestion incomplète peuvent induire des réponses immunitaires acquises et innées. L’objectif principal de cette thèse était de tester un nouveau traitement d’appoint de la maladie cœliaque utile lors de voyages ou d’évènements ponctuels. Dans les années 80, une observation italienne montra l’inhibition de certains effets induits par des gliadines digérées sur des cultures cellulaires grâce à la co-incubation en présence de mannane: un polyoside naturel composé de mannoses. Malheureusement, ce traitement n’était pas applicable in vivo à cause de la dégradation par les enzymes du tractus gastro-intestinales du polymère, de par sa nature osidique. Les polymères de synthèse, grâce à la diversité et au contrôle de leurs propriétés physico-chimiques, se révèlent être une alternative attrayante à ce polymère naturel. L’objectif de cette recherche était d’obtenir un polymère liant la gliadine, capable d’interférer dans la genèse de la maladie au niveau du tube digestif, afin d’abolir les effets délétères induits par la protéine. Tout d’abord, des copolymères de type poly (hydroxyéthylméthacrylate)-co-(styrène sulfonate) (P(HEMA-co-SS)) ont été synthétisés par polymérisation radicalaire contrôlée par transfert d’atome (ATRP). Une petite bibliothèque de polymères a été préparée en faisant varier la masse molaire, ainsi que les proportions de chacun des monomères. Ces polymères ont ensuite été testés quant à leur capacité de complexer la gliadine aux pH stomacal et intestinal et les meilleurs candidats ont été retenus pour des essais cellulaires. Les travaux ont permis de montrer que le copolymère P(HEMA-co-SS) (45:55 mol%, 40 kDa) permettait une séquestration sélective de la gliadine et qu’il abolissait les effets induits par la gliadine sur différents types cellulaires. De plus, ce composé interférait avec la digestion de la gliadine, suggérant une diminution de peptides immunogènes impliqués dans la maladie. Ce candidat a été testé in vivo, sur un modèle murin sensible au gluten, quant à son efficacité vis-à-vis de la gliadine pure et d’un mélange contenant du gluten avec d’autres composants alimentaires. Le P(HEMA-co-SS) a permis de diminuer les effets sur les paramètres de perméabilité et d’inflammation, ainsi que de moduler la réponse immunitaire engendrée par l’administration de gliadine et celle du gluten. Des études de toxicité et de biodistribution en administration aigüe et chronique ont été réalisées afin de démontrer que ce dernier était bien toléré et peu absorbé suite à son administration par la voie orale. Enfin des études sur des échantillons de tissus de patients souffrants de maladie cœliaque ont montré un bénéfice therapeutique du polymère. L’ensemble des travaux présentés dans cette thèse a permis de mettre en évidence le potentiel thérapeutique du P(HEMA-co-SS) pour prévenir les désordres reliés à l’ingestion de gluten, indiquant que ce type de polymère pourrait être exploité dans un avenir proche. / Celiac Disease or celiac sprue is identified as a gluten intolerance. It is an inflammatory disorder of the intestine triggered by the ingestion of gluten in genetically susceptible individuals. This condition is highly prevalent because it affects up to 1% of the worldwide population. Nowadays, there is no pharmacological treatment available to treat or off set to the disease. Due to the huge progress in the understanding of the pathogenesis, new therapeutic targets have been discovered. At the present time, the only effective treatment remains the strict lifelong abandonment of the pathogen agent, gluten. Gluten encompasses the storage proteins in wheat, rye and barley. The wheat gluten is divided into glutenins and gliadins. The latter seem to be the most important trigger in the celiac disease. Gliadins and the related proteins (i.e. secalins and hordeins, respectively in rye and barley) are rich in prolin and glutamin residues, conferring them to be resistant by enzymatic digestion. The resulting peptides of the incomplete process may set off the inflammatory reaction. The main objective of this thesis was to test a new supportive therapy in treating celiac disease, useful in punctual occasion (i.e. during travel or social event when the gluten-free property cannot be ascertained). In the 1980’s, inhibition of some gliadin-induced effects on cell cultures were observed owing to mannan co-incubation. However, this compound, due to his osidic nature, may be cleaved by digestive enzymes in vivo. Synthetic polymers prove to be an attracting alternative owing to the tunability of their physical and chemical properties. The goal of this study was to obtain a polymeric gliadin-binder, interferring with the pathogenesis of the celiac disease in the gastro-intestinal tract, to abrogate the gliadin induced effects. Atom transfer radical polymerization was used to synthesize copolymers of the type poly (hydroxyethylméthacrylate)-co-(styren sulfonate) (P(HEMA-co-SS)). A small library of polymers varying in their molecular weight and in their constituting monomers ratio was prepared. The ability of these polymers to sequester gliadin was assessed at stomacal and intestinal pH. The best candidates were further evaluated in cell cultures. Our results revealed that a selective binding was obtained with the P(HEMA-co-SS) (45:55 mol%, 40 kDa). This compound abolished gliadin-induced effects on various cell lines. In addition, gliadin digestion was hindered, suggesting a decrease in the formation of immunogenic peptides known to trigger the diseases. In vivo experiments were additionally carried out on a murine model of gluten-sensitivity with this polymeric candidate. Its efficacy towards pure gliadin and gluten containing food was tested. P(HEMA-co-SS decreased gliadin–induced effect on permeability and inflammatory parameters and modulated the immune response due to gliadin/gluten gavage. Toxicity and biodistribution studies following acute and chronic administration were performed on murine to demonstrate that the polymer was well tolerated and not absorbed after oral administration. Finally, biopsies of patients suffering from CD disease exhibited therapeutic benefit of the polymer. Altogether, the results presented in this thesis evidenced the potential of P(HEMA-co-SS) to prevent the gluten-induced disorder, indicating that this type of polymer may be useful in a near future.

This thesis contains investigations in the area of polymers herein propellants binders are modified functionally to meet the requirements of future energetic propellants. Chapter 1 contains a broad introduction to the area of recent advances in solid propellants and the numerous applications of ‘Click Chemistry’. Chapters 2 details the materials, characterization tools and the experimental techniques employed for the studies. This is followed by Chapter 3, 4, and 5 which deals with functional modification of various propellants binders, their characterisation and evaluation in propellant formulations. Chapter 6 details with the thermal decomposition of diazides and its reaction with alkenes. The advent of modern rockets has opened a new era in the history of space exploration as well as defence applications. The driving force of the rocket emanates from the propellant – either solid or liquid. Composite solid propellants find an indispensable place, in today’s rockets and launch vehicles because of the inherent advantages such as high reliability, easy manufacturing, high thrust etc. The composite propellant consisting of inorganic oxidiser like ammonium perchlorate, (AP), ammonium nitrate (AN) etc), metallic fuel (aluminium powder, boron etc) and polymeric fuel binder (hydroxyl terminated polybutadiene-HTPB, polybutadiene-acrylic acid-acrylonitrile PBAN, glycidyl azide polymer (GAP), polyteramethylene oxide (PTMO) etc. is used in igniters, boosters, upper stage motors and special purpose motors in large launch vehicles. Large composite solid propellant grains or rocket motors in particular, demand adequate mechanical properties to enable them to withstand the stresses imposed during operation, handling, transportation and motor firing. They should also have a reasonably long ‘potlife’ to provide sufficient window for processing operations such as mixing and casting which makes the selection of binder with appropriate cure chemistry more challenging. In all composite solid propellants currently in use, polymers perform the role of a binder for the oxidiser, metallic fuel and other additives. It performs the dual role of imparting dimensional stability to the composite, provides structural integrity and good mechanical properties to the propellant besides acting as a fuel to impart the required energetics. Conventionally, the terminal hydroxyl groups in the binders like GAP, PTMO and HTPB are reacted with diisocyanates to form a polyurethane network, to impart the necessary mechanical properties to the propellant. A wide range of diisocyantes such as tolylene diisocyanate (TDI) and isophorone diisocyanate (IPDI) are used for curing of these binders. However, the incompatability of isocyanates with energetic oxidisers like ammonium dinitramide (ADN), hydrazinium nitroformate (HNF), short ‘potlife’ of the propellant slurry and undesirable side reactions with moisture are limiting factors which adversely affect the mechanical properties of curing binders through this route. The objective of the present study is to evolve an alternate approach of curing these binders is to make use of the 1,3 dipolar addition reactions between azide and alkyne groups which is a part of ‘Click chemistry’. This can be accomplished by the reaction of azide groups of GAP with triple bonds of alkynes and reactions of functionally modified HTPB/PTMO (azide/alkyne) to yield 1,2,3 -triazole based products. This offers an alternate route for processing of solid propellants wherein, the cured resins that have improved mechanical properties, better thermal stability and improved ballistic properties in view of the higher heat of decomposition resulting from the decomposition of the triazole groups. GAP is an azide containing energetic polymer. The azide groups can undergo reaction with alkynes to yield triazoles. In, Chapter 3 the synthesis and characterisation of various alkynyl compounds including bis propargyl succinate (BPS), bis propargyl adipate (BPA), bis propargyl sebacate (BPSc.) and bis propargyl oxy bisphenol A (BPB) for curing of GAP to yield triazoles networks are studied. The mechanism of the curing reaction of GAP with these alkynyl compounds was elucidated using a model compound viz. 2-azidoethoxyethane (AEE). The reaction mechanism has been analysed using Density Functional Theory (DFT) method. DFT based theoretical calculations implied marginal preference for 1, 5 addition over the 1, 4 addition for the uncatalysed cycloaddition reaction between azide and alkyne group. The detailed characterisation of these systems with respect to the cure kinetics, mechanical properties, dynamic mechanical behaviour and thermal decomposition characteristics were done and correlated to the structure of the network. The glass transition temperature (Tg), tensile strength and modulus of the system increased with crosslink density which in turn is, controlled by the azide to alkyne molar stoichiometry. Thermogravimetic analysis (TGA) showed better thermal stability for the GAP-triazole compared to GAP based urethanes. Though there have been a few reports on curing of GAP with alkynes, it is for the first time that a detailed characterisation of this system with respect to the cure kinetics, mechanical, dynamic mechanical, thermal decomposition mechanism of the polymer is being reported. To extent the concept of curing binders through 1,3 dipolar addition reaction, the binder HTPB as chemically transformed to propargyloxy carbonyl amine terminated polybutadiene (PrTPB) with azidoethoxy carbonyl amine terminated polybutadiene (AzTPB) and propargyloxy polybutadiene (PTPB). Similarly, PTMO was convnerted to propargyloxy polytetramethylene oxide (PTMP). Triazole-triazoline networks were derived by the reaction of the binders with alkyne/azide containing curing agents. The cure characteristics of these polymers (PrTPB with AzTPB, PTPB with GAP and PTMP with GAP) were studied by DSC. The detailed characterisations of the cured polymers for were done with respect to the, mechanical, dynamic mechanical behaviour and thermal decomposition characteristics were done. Propellant level studies were done using the triazoles derived from GAP, PrTPB-AzTPB, PTPB and PTMP as binder, in combination with ammonium perchlorate as oxidiser. The propellants were characterised with respect to rheological, mechanical, safety, as well as ballistic properties. From the studies, propellant formulations with improved energetics, safety characteristics, processability and mechanical properties as well defect free propellants could be developed using novel triazole crosslinked based binders. Chapter 6, is aimed at understanding the mechanism of thermal decomposition of diazido compounds in the first section. For this, synthesis and characterisation of a diazido ester 1,6 –bis (azidoacetoyloxy) hexane (HDBAA) was done. There have been no reports on the thermal decomposition mechanism of diazido compounds, where one azide group may influence the decomposition of the other. The thermal decomposition mechanism of the diazido ester were theoretically predicted by DFT method and corroborated by pyrolysis-GC-MS studies. In the second section of this chapter, the cure reaction of the diazido ester with the double bonds of HTPB has been investigated. The chapter 6B reports the mechanism of Cu (I) catalysed azide-alkene reaction validated using density functional theory (DFT) calculations in isomers of hexene (cis-3-hexene, trans-3-hexene and 2-methy pentene: model compound of HTPB) using HDBAA. This the first report on an isocyanate free curing of HTPB using an azide. Chapter 7 of the thesis summarizes the work carried out, the highlights and important findings of this work. The scope for future work such as development of high performance eco-friendly propellants based on triazoles in conjunction with chlorine-free oxidizer like ADN, synthesis of compatible plasticisers and suitable crosslinkers have been described. This work has given rise to one patent, three international publications and four papers in international conferences in the domain.